Clinical Efficacy of Composite Autologous Chylated Fat and Concentrated Growth Factors for Treating Postinjection Alopecia After Facial Fillers: A Single‐Center Retrospective Study
Journal of Cosmetic Dermatology · 2025
DOI: 10.1111/jocd.70269 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2025. Verfasst von Shuo Tang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Senior Department of Burns and Plastic Surgery, The Fourth Medical Center of Chinese PLA General Hospital, Beijing, , China. Hauptthemen laut MEDLINE: Alopecia, Cosmetic Techniques, Dermal Fillers, Intercellular Signaling Peptides and Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Postinjection alopecia is a rare but significant complication of facial fillers, likely caused by compromised microcirculation and follicular damage. Effective treatments are needed, but regenerative therapies specifically for this etiology lack systematic investigation.
Objective
This study evaluated the efficacy and safety of combined autologous chylated fat (ACF) and concentrated growth factors (CGF) for treating acute alopecia following facial filler injection.
Methods
In this single‐center, retrospective case series, nine female patients with acute alopecia (2–4 weeks post‐HA filler) were treated between June 2021 and June 2024. Treatment involved three monthly subcutaneous injections of a 1:1 ACF and liquid CGF mixture (0.1 mL/cm 2 ). Outcomes were assessed at 6 months posttreatment initiation, including hair density, diameter, terminal/vellus ratio, anagen/telogen ratio, Global Aesthetic Improvement Scale (GAIS), and adverse events.
Results
All nine patients completed the 6‐month follow‐up. Significant improvements ( p < 0.001) were observed at 6 months compared to baseline: hair density increased from 32.7 ± 13.4 to 92.4 ± 23.4 hairs/cm 2 , hair diameter from 52.3 ± 15.2 to 75.8 ± 21.7 μm, terminal/vellus ratio from 0.31 ± 0.11 to 1.27 ± 0.35, and anagen proportion from 18.4% ± 6.5% to 63.7% ± 14.9%. GAIS scores indicated high satisfaction. Treatment was well‐tolerated, with only one patient reporting transient erythema.
Conclusion
Combined ACF and CGF represent a promising and effective treatment for post‐filler alopecia, offering a novel therapeutic option for early intervention and improved esthetic outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Senior Department of Burns and Plastic Surgery, The Fourth Medical Center of Chinese PLA General Hospital, Beijing, , China.
- Chinese PLA Medical School, Beijing, China.
Zitieren
APA
Tang, S., Zhou, G., Fu, Q., & Chen, M. (2025). Clinical Efficacy of Composite Autologous Chylated Fat and Concentrated Growth Factors for Treating Postinjection Alopecia After Facial Fillers: A Single‐Center Retrospective Study. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70269
Vancouver
Tang S, Zhou G, Fu Q, Chen M. Clinical Efficacy of Composite Autologous Chylated Fat and Concentrated Growth Factors for Treating Postinjection Alopecia After Facial Fillers: A Single‐Center Retrospective Study. Journal of Cosmetic Dermatology. 2025. doi:10.1111/jocd.70269
BibTeX
@article{Tang2025,
author = {Tang, Shuo and Zhou, Guiwen and Fu, Qiang and Chen, Minliang},
title = {Clinical Efficacy of Composite Autologous Chylated Fat and Concentrated Growth Factors for Treating Postinjection Alopecia After Facial Fillers: A Single‐Center Retrospective Study},
journal = {Journal of Cosmetic Dermatology},
year = {2025},
doi = {10.1111/jocd.70269}
}
EUVIMED